# Crocker Ventures

> Crocker Ventures is a VC fund in Salt Lake City backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Salt Lake City, United States
- Total investments: 4
- Last investment: Feb 2025
- Lead investor: 75%
- Last updated: Aug 2026
- Website: http://www.crockerventures.com

Crocker Ventures is a VC fund in Salt Lake City focused on Health Care and Biotechnology. My time is split between managing the intellectual property of our various start up companies, investigating and acquiring new technologies, and managing one or more of the startup companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Biotechnology | 2 | 50% |
| B2B | 1 | 25% |
| Legal | 1 | 25% |
| Medical | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Seed | 1 | 25% |
| Private Equity | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rebel Medicine | Rebel Medicine is developing safe and effective alternatives to opioid-free pain management. | $6M | Series A | Feb 06, 2025 |  |
| IsoTalent | IsoTalent s a full-service recruiting agency in Lehi, Utah, with clients from around the world. We offer affordable hourly rates, high-touch collaboration with our team of professional recruiters, and tech-backed applicant tracking and screening methods. | $5M | Seed | Aug 15, 2022 |  |
| TellBio | TellBio is a provider of biotechnology service. | $5M | Series A | Mar 16, 2021 |  |
| Merrimack | Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonalantibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts. | $77M | Private Equity | Apr 14, 2011 |  |

4 of 4 investments shown.

## Co-investors
- [Ad Ventures](https://shizune.co/investors/profile/ad-ventures-1e10) — VC Fund, 1 deal together
- ARUP Laboratories — VC Fund, 1 deal together
- Cantina Angels — VC Fund, 1 deal together
- [Central Texas Angel Network](https://shizune.co/investors/profile/central-texas-angel-network) — VC Fund, 1 deal together
- [Credit Suisse](https://shizune.co/investors/profile/credit-suisse) — VC Fund, 1 deal together
- Genetron Health — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Crocker Ventures invest in?

Crocker Ventures invests primarily in Health Care, Biotechnology and B2B startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Crocker Ventures last invest?

The most recent investment recorded for Crocker Ventures closed in Feb 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co